UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

No Superiority of Stents vs Balloon Dilatation for Dominant Strictures in Patients With Primary Sclerosing Cholangitis

Ponsioen, CY; Arnelo, U; Bergquist, A; Rauws, EA; Paulsen, V; Cantú, P; Parzanese, I; ... Aabakken, L; + view all (2018) No Superiority of Stents vs Balloon Dilatation for Dominant Strictures in Patients With Primary Sclerosing Cholangitis. Gastroenterology 10.1053/j.gastro.2018.05.034. (In press).

[img] Text
Ponsioen_AAM.pdf - ["content_typename_Accepted version" not defined]
Access restricted to UCL open access staff until 23 May 2019.

Download (1MB)

Abstract

BACKGROUND & AIMS: Dominant strictures occur in approximately 50% of patients with primary sclerosing cholangitis (PSC). Short-term stents have been reported to produce longer resolution of dominant strictures than single-balloon dilatation. We performed a prospective study to compare the efficacy and safety of balloon dilatation vs short-term stents in patients with non-end stage PSC. METHODS: We performed an open-label trial of patients with PSC undergoing therapeutic endoscopic retrograde cholangiopancreatography (ERCP) at 9 tertiary-care centers in Europe, from July 2011 through April 2016. Patients found to have a dominant stricture during ERCP were randomly assigned to groups that underwent balloon dilatation (n=31) or stent placement for a maximum of 2 weeks (n=34); patients were followed for 24 months. The primary outcome was the cumulative recurrence-free patency of the primary dominant strictures. RESULTS: Study recruitment was terminated after a planned interim analysis because of futility and differences in treatment-related serious adverse events (SAEs) between groups. The cumulative recurrence-free rate did not differ significantly between groups (0.34 for the stent group and 0.30 for the balloon dilatation group at 24 months; P=1.0). Most patients in both groups had reductions in symptoms at 3 months after their procedure. There were 17 treatment-related SAEs: post-ERCP pancreatitis in 9 patients and bacterial cholangitis in 4 patients. SAEs occurred in 15 patients in the stent group (45%) and in only 2 patients in the balloon dilatation group (6.7%) (odds ratio, 11.7; 95% CI, 2.4-57.2; P=.001). CONCLUSIONS: In a multicenter, randomized trial of patients with PSC and a dominant stricture, short-term stents were not superior to balloon dilatation and were associated with a significantly higher occurrence of treatment-related SAEs. Balloon dilatation should be the initial treatment of choice for dominant strictures in patients with PSC. This may be particularly relevant to patients with an intact papilla. ClinicalTrials.gov no: NCT01398917.

Type: Article
Title: No Superiority of Stents vs Balloon Dilatation for Dominant Strictures in Patients With Primary Sclerosing Cholangitis
Location: United States
DOI: 10.1053/j.gastro.2018.05.034
Publisher version: http://doi.org/10.1053/j.gastro.2018.05.034
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
Keywords: biliary, drainage, surgery, temporary stent
URI: http://discovery.ucl.ac.uk/id/eprint/10051321
Downloads since deposit
1Download
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item